Cigna Group, also popularly recognized by its stock ticker symbol 'CI', is a leading global health services organization headquartered in Bloomfield, Connecticut, US. Cigna has a longstanding history dating back to 1792 and has since evolved into a billion-dollar multinational corporation primarily providing health insurance services. With over 73,000 employees worldwide, Cigna serves more than 180 million customer relationships across 30+ countries and jurisdictions.
Cigna’s vast portfolio caters to a variety of healthcare needs including medical, dental, disability, life and accident insurance, as well as Medicare and Medicaid products. The company is committed to its mission of improving the health, well-being, and peace of mind of those it serves. This people-centric perspective consistently drives Cigna’s strategy to plunge into the challenge of a complex healthcare system and pioneer solutions that account for the individual needs of the communities and people it serves.
Cigna’s business model is segmented into five operating divisions: the Health Services division, Integrated Medical division, International Markets, Group Disability and Life, and the Other Operations Division. This enables the company to provide a diverse array of solutions. Cigna also differs from other insurance providers through its pharmacy benefits management services, prescription drug plans, and its data analytics services.
Cigna Group operates with a continuous focus on delivering innovative healthcare solutions by leveraging its vast data and analytics resources to anticipate and understand its customers' health needs. Its commitment to enhancing the customer experience is visible in the digital tools and resources it offers for round-the-clock access to care, and Cigna’s health improvement initiatives designed to address both mental and physical health holistically.
Environmental, Social, and Governance (ESG) responsibility is also crucial for Cigna. They actively work on improving the health of individuals and communities, enhancing responsible business practices, and fostering an inclusive and vibrant workplace.
Cigna is recognized on the global stage for its performance, having been listed on the Fortune 500, and having received multiple accolades in areas like customer service, innovation, and corporate responsibility. Its solid financial strength and customer-focused approach demonstrate that it is not just an insurance provider but a committed health partner. Cigna remains a major player in the global healthcare industry, consistently focusing on improving people's health and well-being through its extensive range of services.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
CVS Health is reportedly considering splitting its retail pharmacy chain from its insurance business, according to the Financial Times. This potential move would undo part of the healthcare conglomerate built through various acquisitions, including the 2018 purchase of Aetna. Discussions are still in the early stages, and no final decision has been made.
Cigna Group (CI) is preparing to report its third-quarter 2026 results, with analysts anticipating a slight decrease in earnings per share but an increase in revenues. While pharmacy and Cigna Healthcare revenues are expected to grow, the Evernorth Health Services segment's pre-tax adjusted income is projected to decline. The article also highlights other medical stocks, Phibro Animal Health Corporation, ProMIS Neurosciences, Inc., and Humana Inc., that show potential for an earnings beat.
Cigna Group (CI) shares fell by 1.02% to $295.19 on Monday, experiencing a second consecutive day of losses despite a mixed trading session for the broader market. The Dow Jones Industrial Average rose 0.41%, while the S&P 500 Index declined by 0.51%.
CVS Health appears pricier than competitors like Cigna based on its P/E ratio, but this is distorted by a significant non-cash goodwill impairment in fiscal Q3 2025. When evaluating actual business performance over the trailing four quarters, CVS shows similar revenue growth and operating margins to Cigna, despite a better total return for CVS shares. The company's raised 2026 earnings forecast and widening margins in 2026 suggest an improved outlook, though risks like reduced Medicare Advantage ratings and substantial debt exist.
Zacks Research has upgraded Healthcare Services Group (NASDAQ:HCSG) from a "hold" to a "strong-buy" rating. This upgrade comes as HCSG shares opened up 2.6% at $24.68, nearing their 12-month high, and after the company reported quarterly EPS of $0.36, surpassing the consensus estimate. Institutional investors hold a significant portion of the stock, while some executives have recently sold shares.
The Cigna Group recently approved a quarterly dividend of $1.56 per share, coinciding with expectations of higher revenue but lower earnings for the September 2026 quarter. This combination highlights a focus on profitability amid revenue expansion and raises questions about the company's investment narrative. Analysts project continued revenue growth but also an earnings increase by 2029, with fair value estimates varying widely among community members.
Cardiac-monitoring company iRhythm Technologies disclosed a data breach that affected 8.2 million people after attackers accessed third-party-hosted business applications. The breach exposed personal, insurance, and device-related information, including names, addresses, dates of birth, and insurance numbers, though clinical and device systems were not affected. iRhythm detected the unauthorized access between June 3 and June 8, 2026, and later faced an extortion attempt.
CVS Health has filed a lawsuit against the U.S. Department of Health & Human Services, asserting that the Center for Medicare & Medicaid Services (CMS) employed improper methods to assign "star ratings" to its Aetna Medicare Advantage plans. The company argues that this dispute could lead to a loss of $2 billion in revenue beginning in 2028. This action follows similar lawsuits and industry-wide reevaluations of Medicare Advantage plans.